United States Últimas notícias

With the US midterm election about six weeks away, President Donald Trump's approval rating is near record lows. Voters now trust Democrats more than Republicans on a laundry list of issues: to handle the economy, health care, immigration, the deficit, cost of living and foreign wars, according to a fresh New York Times/Siena poll. "Inflation is still high, consumers are feeling it" and come polling day, voters will be thinking about "affordability, affordability, affordability", says Timothy O'Brien, Senior Executive Editor for Bloomberg Opinion. O'Brien joins "The Pulse with Francine Lacqua" to discuss what's at stake for the Trump administration, and what voters are most concerned about heading into the election.

BlossomHill Therapeutics (NASDAQ:BLSM) reported second quarter 2026 financial results and pipeline progress, highlighting its strengthened cash position following an upsized initial public offering.

The Cato Corporation (NYSE:CATO) plans to close approximately 70 additional underperforming stores during the third and fourth quarters of fiscal 2026, bringing total planned store closures for the year to about 120 locations.

French Finance Minister Roland Lescure discusses the nation's budget deficit and the impact of fiscal concerns on bond markets as the spread between French and German yields widens. "There has been a bit of a rise in the spread, as you said, between France and Germany," Lescure tells Bloomberg's Oliver Crook in Dublin. "This is mostly linked with the fact that we have budgetary issues. We are tackling them," he adds.

Merck (NYSE:MRK) received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) recommending KEYTRUDA (pembrolizumab) combined with Padcev (enfortumab vedotin-ejfv) for adults with resectable muscle-invasive bladder cancer.

Xenon Pharmaceuticals (NASDAQ:XENE) shares declined after the company temporarily paused new patient enrollment in clinical studies evaluating its drug candidate for major depression and bipolar depression.

Novo Nordisk (NYSE:NVO) received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) recommending once-weekly Sogroya (somapacitan) for children in Europe with idiopathic short stature and persistent growth disturbance.

U.S.-listed gold mining shares gained before the market opened as rising bullion prices lifted the sector, with spot gold reaching $4,377.32 per ounce.

German industrial services giant Bilfinger has had a tough week after delivering a surprise guidance cut. The firm is blaming uncertainty coming from the Iran conflict for the warning and is now saying that it may cut 1500 jobs. CEO Thomas Schulz spoke exclusively with Guy Johnson on "Bloomberg Brief."

The Ensign Group (NASDAQ:ENSG) declared a quarterly cash dividend of $0.0650 per share of common stock, payable on or before October 31, 2026.

Natera (NASDAQ:NTRA) presented new data from its Signatera molecular residual disease (MRD) test at the IASLC 2026 World Conference on Lung Cancer, including results from a 1,129-patient analysis in early-stage non-small cell lung cancer.

Nasdaq 100 futures led U.S. stock futures higher on Friday as declining oil prices reduced some inflation concerns and put the technology-focused index on track for weekly gains.